Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4861544
Max Phase: Preclinical
Molecular Formula: C50H78N18O11
Molecular Weight: 1107.29
Molecule Type: Unknown
Associated Items:
ID: ALA4861544
Max Phase: Preclinical
Molecular Formula: C50H78N18O11
Molecular Weight: 1107.29
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)NCCCNC(=O)NC(=N)NCCC[C@@H](C(=O)N[C@@H](Cc2ccc(O)cc2)C(N)=O)NC1=O
Standard InChI: InChI=1S/C50H78N18O11/c1-28(2)25-37-45(77)63-34(43(75)65-36(41(51)73)26-29-10-14-31(69)15-11-29)9-5-22-60-49(56)68-50(79)61-24-6-23-57-39(71)18-19-40(72)62-33(7-3-20-58-47(52)53)42(74)67-38(27-30-12-16-32(70)17-13-30)46(78)64-35(44(76)66-37)8-4-21-59-48(54)55/h10-17,28,33-38,69-70H,3-9,18-27H2,1-2H3,(H2,51,73)(H,57,71)(H,62,72)(H,63,77)(H,64,78)(H,65,75)(H,66,76)(H,67,74)(H4,52,53,58)(H4,54,55,59)(H4,56,60,61,68,79)/t33-,34-,35-,36-,37-,38-/m0/s1
Standard InChI Key: IAIZTRAAUSPLQL-JPRYDEJLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1107.29 | Molecular Weight (Monoisotopic): 1106.6097 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):